Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: OCTAPHARMA USA INC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2025-05-23 to 2025-06-08
Current total value of award: $100000
Description: OCTAPLASLG FOR WHITE HOUSE MEDICAL UNIT